BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10481114)

  • 1. [Eight year history of neuroblastoma in an adult patient. Value of 123I-MIBG and 111In-DTPA-D-Phe-octreotide scintigraphy].
    Alonso Rodríguez M; Castejón Sánchez I; Mariño Pfeiffer E; Ramos Sanz J; Martínez García G; Escribano Arias M; Freile García I; Peiró Valgañón V; Ortiz Berrocal J
    Rev Esp Med Nucl; 1999 Aug; 18(4):298-301. PubMed ID: 10481114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
    Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
    J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse bone marrow uptake [123I]MIBG in neuroblastoma: an "MIBG super scan" case report.
    Giammarile F; Olier AL; Lumbroso J
    Q J Nucl Med; 1995 Jun; 39(2):119-21. PubMed ID: 8574805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma.
    Sautter-Bihl ML; Dörr U; Schilling F; Treuner J; Bihl H
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):38-41. PubMed ID: 7992079
    [No Abstract]   [Full Text] [Related]  

  • 5. I-131 MIBG scintigraphy of neuroectodermal tumors. Comparison between I-131 MIBG and In-111 DTPA-octreotide.
    Lauriero F; Rubini G; D'Addabbo F; Rubini D; Schettini F; D'Addabbo A
    Clin Nucl Med; 1995 Mar; 20(3):243-9. PubMed ID: 7750219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
    Shulkin BL; Shen SW; Sisson JC; Shapiro B
    J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [123I-metaiodobenzylguanidine (MIBG) scintigraphy for the staging of neuroblastoma].
    Okuyama C; Ushijima Y; Sugihara H; Okitsu S; Maeda T
    Kaku Igaku; 1998 Nov; 35(9):835-42. PubMed ID: 9916399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse bone marrow infiltration of a neuroblastoma mimicking the findings of a bone marrow scan on I-123 MIBG scintigraphy.
    Grüning T; Kropp J; Franke WG
    Clin Nucl Med; 2001 Dec; 26(12):1044. PubMed ID: 11711716
    [No Abstract]   [Full Text] [Related]  

  • 9. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
    Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
    Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma].
    Guerra P
    Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-HYNIC octreotide in neuroblastoma.
    Gambini JP; López Lerena JJ; Quagliata A; Hermida JC; Heuguerot C; Alonso O
    Ann Nucl Med; 2008 Nov; 22(9):817-9. PubMed ID: 19039561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
    Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
    J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML; Bihl H; Heinze HG
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor scintigraphy (SRS): a new diagnostic tool in neuroblastoma (NB)?
    Dörr U; Sautter-Bihl ML; Schilling FH; Koscielniak E; Treuner J; Bihl H
    Prog Clin Biol Res; 1994; 385():355-61. PubMed ID: 7972231
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
    Kroiss A; Putzer D; Uprimny C; Decristoforo C; Gabriel M; Santner W; Kranewitter C; Warwitz B; Waitz D; Kendler D; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2011 May; 38(5):865-73. PubMed ID: 21279352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
    El-Maghraby T
    Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites].
    Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O
    Nuklearmedizin; 1996 Dec; 35(6):220-4. PubMed ID: 8999421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could somatostatin scintigraphy be superior to MIBG scan in the staging of stage IVs neuroblastoma (Pepper's syndrome)?
    Manil L; Edeline V; Michon J; Neuenschwander S; Lequen H; Lavocat C; Zucker JM
    Clin Nucl Med; 1996 Jul; 21(7):530-3. PubMed ID: 8818464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
    Shulkin BL; Shapiro B; Hutchinson RJ
    J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.